213 related articles for article (PubMed ID: 23303039)
1. Atypical adenomatous hyperplasia of the prostate mimicking adenocarcinoma lesion: case report and literature review.
Enciu M; Aşchie M; Boşoteanu M; Chisoi A
Rom J Morphol Embryol; 2012; 53(4):1093-6. PubMed ID: 23303039
[TBL] [Abstract][Full Text] [Related]
2. Is atypical adenomatous hyperplasia of the prostate a precursor lesion?
Zhang C; Montironi R; MacLennan GT; Lopez-Beltran A; Li Y; Tan PH; Wang M; Zhang S; Iczkowski KA; Cheng L
Prostate; 2011 Dec; 71(16):1746-51. PubMed ID: 21480308
[TBL] [Abstract][Full Text] [Related]
3. Mesonephric remnant hyperplasia involving prostate and periprostatic tissue: findings at radical prostatectomy.
Chen YB; Fine SW; Epstein JI
Am J Surg Pathol; 2011 Jul; 35(7):1054-61. PubMed ID: 21606823
[TBL] [Abstract][Full Text] [Related]
4. Adenosis (atypical adenomatous hyperplasia): histopathology and relationship to carcinoma.
Epstein JI
Pathol Res Pract; 1995 Sep; 191(9):888-98. PubMed ID: 8606870
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer.
Shah RB; Zhou M; LeBlanc M; Snyder M; Rubin MA
Am J Surg Pathol; 2002 Sep; 26(9):1161-8. PubMed ID: 12218572
[TBL] [Abstract][Full Text] [Related]
6. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference.
Epstein JI; Egevad L; Humphrey PA; Montironi R;
Am J Surg Pathol; 2014 Aug; 38(8):e6-e19. PubMed ID: 25029122
[TBL] [Abstract][Full Text] [Related]
7. False positive labeling of prostate cancer with high molecular weight cytokeratin: p63 a more specific immunomarker for basal cells.
Ali TZ; Epstein JI
Am J Surg Pathol; 2008 Dec; 32(12):1890-5. PubMed ID: 18813120
[TBL] [Abstract][Full Text] [Related]
8. Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?
Brausi M; Castagnetti G; Dotti A; De Luca G; Olmi R; Cesinaro AM
J Urol; 2004 Sep; 172(3):906-8; discussion 908-9. PubMed ID: 15310995
[TBL] [Abstract][Full Text] [Related]
9. Atypical sclerosing adenosis of the prostate: a rare mimic of adenocarcinoma.
Cheng L; Bostwick DG
Histopathology; 2010 Apr; 56(5):627-31. PubMed ID: 20459573
[TBL] [Abstract][Full Text] [Related]
10. Expression of alpha-Methylacyl-CoA racemase (P504S) in atypical adenomatous hyperplasia of the prostate.
Yang XJ; Wu CL; Woda BA; Dresser K; Tretiakova M; Fanger GR; Jiang Z
Am J Surg Pathol; 2002 Jul; 26(7):921-5. PubMed ID: 12131160
[TBL] [Abstract][Full Text] [Related]
11. [The application of high molecular weight cytokeratin in differential diagnosis of prostate adenocarcinoma].
Kong X; Deng F; Wang J
Zhonghua Bing Li Xue Za Zhi; 1996 Aug; 25(4):199-201. PubMed ID: 9275650
[TBL] [Abstract][Full Text] [Related]
12. Pitfalls in the diagnosis of prostate adenocarcinoma from holmium resection of the prostate.
Gan E; Costello A; Slavin J; Stillwell RG
Tech Urol; 2000 Sep; 6(3):185-8. PubMed ID: 10963483
[TBL] [Abstract][Full Text] [Related]
13. Benign mimics of prostatic adenocarcinoma on needle biopsy.
Gaudin PB; Reuter VE
Anat Pathol; 1997; 2():111-34. PubMed ID: 9575372
[TBL] [Abstract][Full Text] [Related]
14. Associations among benign prostate hypertrophy, atypical adenomatous hyperplasia and latent carcinoma of the prostate.
Stamatiou K; Alevizos A; Natzar M; Mihas C; Mariolis A; Michalodimitrakis E; Sofras F
Asian J Androl; 2007 Mar; 9(2):229-33. PubMed ID: 16751999
[TBL] [Abstract][Full Text] [Related]
15. Benign mimics of prostate cancer.
Egevad L; Delahunt B; Furusato B; Tsuzuki T; Yaxley J; Samaratunga H
Pathology; 2021 Jan; 53(1):26-35. PubMed ID: 33070957
[TBL] [Abstract][Full Text] [Related]
16. The spectrum of morphology in non-neoplastic prostate including cancer mimics.
Montironi R; Scarpelli M; Mazzucchelli R; Cheng L; Lopez-Beltran A
Histopathology; 2012 Jan; 60(1):41-58. PubMed ID: 22212077
[TBL] [Abstract][Full Text] [Related]
17. [Histopathological features of prostate cancer].
Kozuka Y; Imai H; Yamanaka M; Kozuka M; Uchida K; Shiraishi T
Nihon Rinsho; 2005 Feb; 63(2):231-6. PubMed ID: 15714971
[TBL] [Abstract][Full Text] [Related]
18. [Low-stage prostatic adenocarcinoma and atypical lesions of the prostate].
Maganto Pavón E; García González R; Ruiz Zárate C; Fernández González I; Fernández Fernández A; Vallejo Herrador J; Mateos Torres A; Escudero Barrilero A
Arch Esp Urol; 1990; 43(9):967-70. PubMed ID: 1708979
[TBL] [Abstract][Full Text] [Related]
19. Nucleolar and AgNOR-analysis of prostatic intraepithelial neoplasia (PIN), atypical adenomatous hyperplasia (AAH) and prostatic carcinoma.
Helpap B; Riede C
Pathol Res Pract; 1995 Jun; 191(5):381-90. PubMed ID: 7479355
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical antibody cocktail staining (p63/HMWCK/AMACR) of ductal adenocarcinoma and Gleason pattern 4 cribriform and noncribriform acinar adenocarcinomas of the prostate.
Herawi M; Epstein JI
Am J Surg Pathol; 2007 Jun; 31(6):889-94. PubMed ID: 17527076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
